The European Paediatric Network for Haemophilia Management ( PedNet Registry)

NCT02979119 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2025-09-16

No results posted yet for this study

Summary

Rationale:

Haemophilia is a rare disease; to improve knowledge international collaboration is needed. Well-defined clinical data will be collected from complete cohorts in order to prevent selection bias.

Objective:

To collect data on bleeding during neonatal period, endogenous (genetic) and exogenous (treatment-related) determinants of inhibitor development and long term outcome.

Conditions

  • Factor VIII Deficiency
  • Factor IX Deficiency

Sponsors & Collaborators

  • PedNet Haemophilia Research Foundation

    lead OTHER

Principal Investigators

  • Gili Kenet, PhD, MD · The National Hemophilia Center Ministry of Health Sheba Medical Center Ramat Gan, Israel

  • Christoph Male, MD · Medical University of Vienna

  • Gili Kenet, PhD, MD · The National Hemophilia Center Ministry of Health Sheba Medical Center Ramat Gan, Israel

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2039-12-31
Completion
2039-12-31

Countries

  • Austria
  • Belgium
  • Canada
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Ireland
  • Israel
  • Italy
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02979119 on ClinicalTrials.gov